Fibromyalgia Treatment Market Report 2026

Fibromyalgia Treatment Market Overview

• Fibromyalgia Treatment market size has reached to $2.89 billion in 2025 • Expected to grow to $3.67 billion in 2030 at a compound annual growth rate (CAGR) of 5% • Growth Driver: Rise In The Aging Population Drives The Growth Of The Fibromyalgia Treatment Market • Market Trend: Market Leaders Focus On Innovative Computerized Behavioral Therapy Devices For Fibromyalgia Treatment Advancements • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Fibromyalgia Treatment Market?

Fibromyalgia treatment refers to the medications used to treat fibromyalgia, a complex and chronic medical condition characterized primarily by widespread and often debilitating musculoskeletal pain, along with a range of other symptoms. The treatment for fibromyalgia helps reduce the disease's severity and manage the symptoms and complications associated with the disease. The main types of fibromyalgia treatment are symptomatic treatment and targeted treatment. Symptomatic treatment, also known as palliative or supportive care, focuses on managing the individual symptoms and improving the patient's overall quality of life. The various drug class includes antidepressants, antiepileptics, muscle relaxants, analgesics and others that are distributed through various distribution channels such as hospital pharmacy, retail pharmacy and online pharmacy.

What Is The Fibromyalgia Treatment Market Growth Forecast?

The fibromyalgia treatment market size is expected to see strong growth in the next few years. It will grow to $3.67 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to development of targeted pain therapies, growth in personalized treatment plans, increased adoption of digital pain management tools, expansion of integrative therapies, rising mental health awareness. Major trends in the forecast period include rising use of symptom-based drug therapies, increased adoption of multimodal treatment approaches, growing focus on chronic pain management, expansion of non-pharmacological therapies, improved patient-centered care models.

Global Fibromyalgia Treatment Market Segmentation

1) By Type: Symptomatic Treatment, Targeted Treatment 2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs 3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Subsegments: 1) By Symptomatic Treatment: Pain Relievers, Antidepressants, Anti-seizure Medications, Sleep Aids, Physical Therapy 2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT), Lifestyle Modifications, Complementary Therapies, Medications Targeting Specific Symptoms

What Is The Driver Of The Fibromyalgia Treatment Market?

The rise in the aging population is expected to drive the growth of the fibromyalgia treatment market. An aging population refers to a demographic phenomenon characterized by an increasing proportion of elderly individuals within a society or population. Fibromyalgia treatment can be particularly helpful for the aging population because older individuals are more susceptible to developing fibromyalgia, and they often experience more severe symptoms due to age-related factors. For instance, in 2023, according to Age UK, a UK-registered charity, reports that in 2023 there are 11 million people aged over 65 in England. This is projected to increase by 10% in the next five years and by 32% by 2043 (1.1 and 3.5 million people, respectively). The population aged 85+, the age group most likely to need health and care services, is also projected to rise rapidly, increasing by 8.2% in the next five years and by 62.7% by 2043 (126,000 and 956,000 people, respectively). Therefore, the rise in the aging population drives the growth of the fibromyalgia treatment industry.

Key Players In The Global Fibromyalgia Treatment Market

Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., AbbVie Inc., Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Endo International plc, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited, Tonix Pharmaceuticals, Allergan plc, Aptinyx Inc., Novartis AG, Merck & Co Inc.

Global Fibromyalgia Treatment Market Trends and Insights

Major companies operating in the fibromyalgia treatment market are focusing on developing technologically advanced solutions, such as computerized behavioral therapy devices, to gain a competitive advantage. A computerized behavioral therapy device is a software-based prescription treatment that delivers structured psychological interventions, such as Acceptance and Commitment Therapy (ACT), via a digital platform. For instance, in May 2023, Swing Therapeutics, a U.S.-based digital therapeutics company, received FDA De Novo authorization for Stanza, a prescription smartphone-based digital therapy that delivers a 12-week self-guided ACT program; it demonstrated significant improvements in pain, fatigue, sleep, and mood in its pivotal PROSPER-FM Phase 3 trial. Stanza is available via Swing Care, a virtual specialty clinic that integrates prescription digital therapy with comprehensive fibromyalgia management. This trend enhances patient access, reduces reliance on pharmacologic treatments, and aligns with guideline-driven non-drug care, though challenges remain in scaling reimbursement and clinician adoption.

What Are Latest Mergers And Acquisitions In The Fibromyalgia Treatment Market?

In April 2023, XRHealth, a US-based telemedicine company that provides fibromyalgia treatment, merged with Amelia Virtual Care under the XRHealth brand name. Through this merger, both companies have facilitated the consolidation of XRHealth and Amelia Virtual Care into a unified entity, enabling them to pool their expertise, technologies, and resources. This combines XRHealth's immersive and augmented reality technology with Amelia Virtual Care's comprehensive virtual reality software for mental health professionals. Amelia Virtual Care, a Spain-based VR treatment solutions company.

Regional Outlook

North America was the largest region in the fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Fibromyalgia Treatment Market?

The fibromyalgia treatment market consists of revenues earned by providing medical diagnosis and evaluation, personalized treatment planning, medication management, pain management clinics and physical therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The fibromyalgia treatment market also includes sales of pain relievers, sleeping aids and anti-anxiety medications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Fibromyalgia Treatment Market Report 2026?

The fibromyalgia treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the fibromyalgia treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.